A Multicentre, Randomised, Double-blind, Placebo-control

Project: Research project

Project Details


A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study Evaluating the Efficacy and Safety of Two Doses of Anifrolumab in Adult Subjects with Active Systematic Lupus Erythematosus (protocol D3461C00005)
Effective start/end date7/1/1612/31/20


  • AstraZeneca

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.